05 October 2023, Calgary: Corteva, Inc. announced the commercial launch of Straxan™ fungicide seed treatment in Canada, bringing farmers a new, ready-to-use and easy-to-apply formulation that targets prominent seed and soil-borne cereal diseases.
The latest offering from Corteva Agriscience’s leading cereal protection portfolio, Straxan fungicide seed treatment provides advanced protection against early season diseases – such as Fusarium species, Rhizoctonia, true loose smut and more – to help maximize crop stand establishment and yield potential. This level of protection is a result of Straxan fungicide seed treatment’s high-quality formulation of proven active ingredients.
“Protecting yield potential from persistent diseases will always be a priority for cereal farmers, which is why it was important for us to bring a complete and versatile option like Straxan fungicide seed treatment to the Western Canadian market,” said Kirsten Ratzlaff, Portfolio Manager, Seed Applied Technologies & Biologicals, Corteva Agriscience. “In addition to its strong disease protection, Straxan offers an easy-to-apply formulation that provides flexibility – both through commercial seed treaters and on-farm equipment – and stable application under varying conditions and temperatures.”
Straxan fungicide seed treatment is a highly compatible formulation and can be used with multiple seed treatment products. This includes Lumivia™ CPL insecticide seed treatment, which delivers the broadest cereal seedling insect protection on the market for long-lasting control of wireworms, cutworms and more. When mixed with Straxan fungicide seed treatment, farmers get a complete cereal seed treatment package.
“Seed treatments help crops get off to their best possible start, and Corteva continues to invest in R&D to deliver robust seed treatment offerings to Canadian farmers,” said Ratzlaff. “Straxan fungicide seed treatment fortifies Corteva’s industry-leading cereal protection portfolio, equipping farmers with a tool that will help each seed reach its genetic potential.”
